Skip to main content
Journal cover image

Interferon in the treatment of cutaneous T-cell lymphoma.

Publication ,  Journal Article
Olsen, EA; Bunn, PA
Published in: Hematol Oncol Clin North Am
October 1995

All of the recombinant interferons are active agents for the systemic treatment of mycosis fungoides and Sézary syndrome. The response rates are similar to those observed with systemic chemotherapy. There is no clear evidence that combining interferons with other systemic therapies increases the response rates. The combination of interferon with PUVA provides provocative results. The optimal role of interferons in the treatment of mycosis fungoides and Sézary's syndrome is undefined.

Duke Scholars

Published In

Hematol Oncol Clin North Am

ISSN

0889-8588

Publication Date

October 1995

Volume

9

Issue

5

Start / End Page

1089 / 1107

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Recombinant Proteins
  • Oncology & Carcinogenesis
  • Lymphoma, T-Cell, Cutaneous
  • Interferons
  • Interferon-gamma
  • Interferon-beta
  • Interferon Type I
  • Humans
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Olsen, E. A., & Bunn, P. A. (1995). Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 9(5), 1089–1107.
Olsen, E. A., and P. A. Bunn. “Interferon in the treatment of cutaneous T-cell lymphoma.Hematol Oncol Clin North Am 9, no. 5 (October 1995): 1089–1107.
Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995 Oct;9(5):1089–107.
Olsen, E. A., and P. A. Bunn. “Interferon in the treatment of cutaneous T-cell lymphoma.Hematol Oncol Clin North Am, vol. 9, no. 5, Oct. 1995, pp. 1089–107.
Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995 Oct;9(5):1089–1107.
Journal cover image

Published In

Hematol Oncol Clin North Am

ISSN

0889-8588

Publication Date

October 1995

Volume

9

Issue

5

Start / End Page

1089 / 1107

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Recombinant Proteins
  • Oncology & Carcinogenesis
  • Lymphoma, T-Cell, Cutaneous
  • Interferons
  • Interferon-gamma
  • Interferon-beta
  • Interferon Type I
  • Humans
  • Combined Modality Therapy